SGLT2 inhibitors for primary prevention of macrovascular and major microvascular complications in type 2 diabetes: an island-wide cohort study

Journal of the Royal Society of Medicine · Published 2025-11-01 · DOI 10.1177/01410768251375906

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1177/01410768251375906

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2025

Related articles